Difference between revisions of "Team:BGU ISRAEL/Parts"

Line 74: Line 74:
 
                     <div class="OverviewBox">
 
                     <div class="OverviewBox">
 
                         <div class="row">
 
                         <div class="row">
                             <div class="col-lg-8">
+
                             <div class="col-lg-6">
 
                                 <p class="bigAssHeader">Overview</p>
 
                                 <p class="bigAssHeader">Overview</p>
                                <hr>
 
 
                                 <div class="partOverviewText">
 
                                 <div class="partOverviewText">
 
                                     <p>
 
                                     <p>
Line 83: Line 82:
 
                                     <ol>
 
                                     <ol>
 
                                         <li>
 
                                         <li>
                                             The chassis for our project is based on the <i>Pseudomonas putida</i> bacterium, for its ability to utilize aromatic molecules, mainly focusing on protocatechuate. We have decided to contribute the the iGEM part repository by submitting the genes encoding the enzymes participating in the protocatechuate degradation pathway, in which Protocatechuate, a toxic molecule for most bacteria, is converted to 3-oxoadipate. One of the genes, pcaB, had 4 PstI restriction cut sites and we did not have enough time to introduce silent mutations to the sequence, hence we did not clone and submit it.  
+
                                             The chassis for our project is based on the <i>Pseudomonas putida</i> bacterium, for its ability to utilize aromatic molecules, mainly focusing on protocatechuate. We have decided to contribute the the iGEM part repository by submitting the genes encoding the enzymes participating in the protocatechuate degradation pathway, in which Protocatechuate, a toxic molecule for most bacteria, is converted to 3-oxoadipate. One of the genes, pcaB, had 4 PstI restriction cut sites and we did not have enough time to introduce silent mutations to the sequence, hence we did not clone and submit it. All 4 other genes were cloned into the pSB1C3 vector and submitted. 
 
                                         </li>
 
                                         </li>
 
                                         <li>
 
                                         <li>
 
                                             Another part of our project involves engineering of the LC-Cutinase protein. We have chosen the LC-Cutinase protein as a target for rational mutagenesis for its PET degrading activity, and using the PROSS algorithm produced 4 mutants.  
 
                                             Another part of our project involves engineering of the LC-Cutinase protein. We have chosen the LC-Cutinase protein as a target for rational mutagenesis for its PET degrading activity, and using the PROSS algorithm produced 4 mutants.  
 
                                             We have also designed a codon optimized version of the W.T. protein.  
 
                                             We have also designed a codon optimized version of the W.T. protein.  
 +
                                            We have cloned and submitted all 5 LC-Cutinase variants.
 
                                         </li>
 
                                         </li>
 
                                     </ol>
 
                                     </ol>
Line 93: Line 93:
 
                                 </div>
 
                                 </div>
 
                             </div>
 
                             </div>
                             <div class="col-lg-4">
+
                             <div class="col-lg-6">
 
                                 <img class="partOverviewPic" src="https://static.igem.org/mediawiki/2016/b/b6/BioBrick_overviewBGU.png">
 
                                 <img class="partOverviewPic" src="https://static.igem.org/mediawiki/2016/b/b6/BioBrick_overviewBGU.png">
 
                                 <br>
 
                                 <br>
                                 <a href="https://2016.igem.org/Team:BGU_ISRAEL/Basic_Part" class="btn btn-primary infobtn" role="button">Come see our BioBricks</a>
+
                                 <div class='row'>
 +
                                    <div class='col-lg-1'></div>
 +
                                    <div class='col-lg-5'>
 +
                                        <a href="https://2016.igem.org/Team:BGU_ISRAEL/Basic_Part" class="btn btn-primary infobtn" role="button">Basic Parts</a>
 +
                                    </div>
 +
                                    <div class='col-lg-5'>
 +
                                        <a href="https://2016.igem.org/Team:BGU_ISRAEL/ImprovedParts" class="btn btn-primary infobtn" role="button">Improved Parts</a>
 +
                                    </div>
 +
                                </div>
 +
                               
 
                             </div>
 
                             </div>
 
                         </div>
 
                         </div>
Line 103: Line 112:
 
             </div>
 
             </div>
 
         </div>
 
         </div>
 +
 +
 
             <a href="#" class="back-to-top">
 
             <a href="#" class="back-to-top">
 
             <img src='https://static.igem.org/mediawiki/2016/5/52/Arrow_for_site.png'>
 
             <img src='https://static.igem.org/mediawiki/2016/5/52/Arrow_for_site.png'>

Revision as of 14:38, 18 October 2016

PlastiCure

Overview

We have decided to submit 9 new BioBricks this year, which are separated into 2 categories:

  1. The chassis for our project is based on the Pseudomonas putida bacterium, for its ability to utilize aromatic molecules, mainly focusing on protocatechuate. We have decided to contribute the the iGEM part repository by submitting the genes encoding the enzymes participating in the protocatechuate degradation pathway, in which Protocatechuate, a toxic molecule for most bacteria, is converted to 3-oxoadipate. One of the genes, pcaB, had 4 PstI restriction cut sites and we did not have enough time to introduce silent mutations to the sequence, hence we did not clone and submit it. All 4 other genes were cloned into the pSB1C3 vector and submitted.
  2. Another part of our project involves engineering of the LC-Cutinase protein. We have chosen the LC-Cutinase protein as a target for rational mutagenesis for its PET degrading activity, and using the PROSS algorithm produced 4 mutants. We have also designed a codon optimized version of the W.T. protein. We have cloned and submitted all 5 LC-Cutinase variants.

Address:

Ben-Gurion University of the Negev
Ben Gurion 1, Beer Sheva 8410501, Israel

Mail: igembgu2016@gmail.com

Connect With Us!